Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
You can read the FDAs patient safety guidance on unapproved GLP-1 drugs used for weight loss
Structure of PEG Loxenatide Tirzepatide Tirzepatide is a dual GIP/GLP-1 receptor agonist that activates both the GLP-1 and GIP signaling pathways
Pro tip: rest one on your coffee cup for 30 seconds first
Follow-up involves scheduling your next visit based on the protocol, tracking weight, measurements, and subjective energy over several weeks, and adjusting frequency or dose if side effects or a lack of benefit emerge
For FDA-approved brand-name options, Wegovy injectable starts at $199 per month for new self-pay patients through NovoCare, while Zepbound begins at $299 per month through LillyDirect
